The canonical Wnt signaling plays important roles in embryonic development and tumorigenesis. For the latter, induced mutations in mice have greatly contributed to our understanding of the molecular mechanisms of cancer initiation and progression. Here, I will review recent reports on gastrointestinal cancer model mice, with an emphasis on the roles of the Wnt signal pathway. They include: mouse models for familial adenomatous polyposis; modifying factors that affect mouse intestinal polyposis, including the genes that help cancer progression; Wnt target genes that affect mouse intestinal polyposis; and a mouse model of gastric cancer that mimics Helicobacter pyroli infection.
The canonical Wnt signaling plays important roles in embryonic development and tumorigenesis. For the latter, induced mutations in mice have greatly contributed to our understanding of the molecular mechanisms of cancer initiation and progression. Here, I will review recent reports on gastrointestinal cancer model mice, with an emphasis on the roles of the Wnt signal pathway. They include: mouse models for familial adenomatous polyposis; modifying factors that affect mouse intestinal polyposis, including the genes that help cancer progression; Wnt target genes that affect mouse intestinal polyposis; and a mouse model of gastric cancer that mimics Helicobacter pyroli infection. Oncogene (2006 Oncogene ( ) 25, 7522-7530. doi:10.1038 Keywords: Wnt; Apc; b-catenin; colon cancer; gastric cancer
Human colon cancer and Wnt signal stimulation
Colon cancer is one of the leading causes of cancer death in industrialized countries. Based on its genetic origin, colon cancers can be divided into two major classes; polyposis colon cancer, and non-polyposis colon cancer. Genes whose mutations are responsible for colon carcinogenesis have been discovered through molecular genetic studies of hereditary cancer predisposition syndromes such as familial adenomatous polyposis (FAP), and hereditary non-polyposis colon cancer (HNPCC). FAP is a hereditary disease with dominant inheritance that causes numerous colon polyps. Although the polyps are benign adenomas, some of them will develop into malignant adenocarcinomas eventually, if left untreated. The adenomatous polyposis coli (APC) gene was identified on human chromosome 5q as one of the genes commonly deleted in some FAP kindreds (Groden et al., 1991; Kinzler et al., 1991) . It encodes a huge protein of about 2850 amino-acid residues, forms a complex with axin and helps glycogen synthase kinase (GSK) 3b to phosphorylate N-terminal serine/threonine residues of b-catenin, accelerating its rapid degradation through ubiquitylation (Polakis, 1999) . If the APC gene is mutated, GSK3b cannot phosphorylate b-catenin. Unphosphorylated and therefore stabilized b-catenin accumulates in the cytoplasm, then moves to the nucleus where it activates T-cell factor (TCF)/LEF transcription factors, inducing a set of new genes: Wnt target genes (Korinek et al., 1997) (Figure 1) . Activation of the canonical Wnt pathway in the colonic epithelium appears to be one of the key events in the polyp initiation process (Oshima et al., 1997) .
Mouse models for FAP
Induced mutations of the Apc gene in mice have provided animal models that are similar to human colon polyposis, although most polyps are formed in the small intestine rather than in the colon. To these mouse models, many additional mutations have been introduced, and their roles as modifiers for adenoma expansion or progression to cancer have been studied extensively.
Apc

Min , Apc
D716
, Apc 1638N and other Apc mutant mice
The first mouse mutant in the Apc gene (the mouse homolog of human APC on mouse chromosome (Chr) 18) was found from a colony of randomly mutagenized mice (Moser et al., 1990) . This mutant, multiple intestinal neoplasia (Min) was found to carry a truncation mutation at codon 850 of the Apc gene (Su et al., 1992) , hence Apc Min . In the C57BL/6 background, the heterozygote develops B30 polyps in the small intestine. With the gene knockout technology, several Apc mutations have been constructed. Apc D716 contains truncating mutation at codon 716, whereas Apc 1638N at codon 1638 (Fodde et al., 1994; Oshima et al., 1995) . Like in Apc Min mice, both knockout mutants develop polyps mainly in the small intestine. Histologically, all these Apc mutants form polyp adenomas indistinguishable from each other. Interestingly, however, the polyp numbers are very different, even in the same C57BL/6J background. Namely, Apc D716 develops usually B300 polyps, whereas Apc 1638N forms only B3 polyps. The major factor that affects the polyp multiplicity among these mutants appears to be the extent of Wnt signal activation. Using Apc D716 mice, we demonstrated that polyp formation is initiated by loss of heterozygosity (LOH) at the Apc locus in the proliferative zone cells (Oshima et al., 1995) , followed by formation of outpocket in the intestinal crypt (Figure 2) (Oshima et al., 1997) . The results suggested that APC protein is essential for the proliferative zone cells to migrate along the crypt-villus axis, either directly or through Wnt signal activation.
We have recently constructed two hypomorphic Apc alleles Apc neoR and Apc neoF whose expression levels were reduced to 20 and 10% of the wild type, respectively (Li et al., 2005) . In these alleles, neomycin resistance gene cassette (neo) was placed in intron 13, sandwiched by the loxP sequences, in either backward (neoR) or forward (neoF) orientation. In the intestinal epithelium of the heterozygous mice, low levels of wild-type APC protein remains even after loss of the wild-type allele by LOH. Their tumor multiplicity was much lower than that in Apc D716 mice. In the embryonic stem cells homozygous for Apc neoR or Apc neoF , both the b-catenin accumulation and b-catenin/TCF transcriptional activity were inversely correlated with the amount of APC protein. These results suggest that reduced APC protein levels increase intestinal polyp multiplicity through quantitative stimulation of the b-catenin/TCF transcription. We estimated the threshold of APC protein level that forms one polyp per mouse as B15% of the wild type. These results also suggest therapeutic implications concerning Wnt signal inhibitors (Li et al., 2005) . Such quantitative nature of Wnt signaling is also suggested in the embryonic differentiation (Kielman et al., 2002) .
Despite the numerous polyps developing in the small intestine in the Apc D716 (as well as in Apc Min ) mice, only a few polyps are formed in the colon, although the penetrance is complete. We have recently constructed a mutant mouse strain in which numerous polyps develop in the distal colon; see below (Aoki et al., 2003) .
In these mutant mice, one of the Apc alleles is mutated in all somatic cells. Therefore, tumorigenesis depends on the relatively rare events of LOH. Recently, another Apc gene knockout mutant was reported where both Apc alleles were mutated simultaneously in a tissue-specific manner using the cre-loxP system (Reed et al., 2004) . Although it is quite an artificial system, it has revealed early changes in the intestinal cell physiology. Namely, loss of Apc product caused perturbed differentiation, migration, proliferation and apoptosis.
Modifier genes of Apc intestinal polyposis
A variety of genes affect intestinal tumorigenesis initiated by Wnt signal activation. Such effects have been investigated by introducing their mutations into the Apc mutant polyposis mice. Introduction of cyclooxygenase (COX)-2 gene mutation dramatically decreases the polyp number in Apc polyposis mice (Figure 3) (Oshima et al., 1996) . We first determined expression of COX-2 protein in intestinal polyps of various sizes, and found that COX-2 was expressed from a very early stage of polyp formation. We then introduced a COX-2 gene (Ptgs2) knockout mutation into the Apc D716 mice, and discovered that both the number and size of polyps were reduced dramatically in the compound mutant mice, in a mutated gene dosagedependent manner. To confirm the results with a pharmaceutical compound, we further dosed Apc D716 mice with COX-2 inhibitors, and demonstrated that the polyp number can be reduced in a dosage-dependent manner (Oshima et al., 1996 ). These results gave the rationale to treat human FAP patients with COX-2 inhibitors such as celecoxib or rofecoxib, and clinical trials confirmed the results of animal experiments (Steinbach et al., 2000; Higuchi et al., 2003) . Following these experiments, a number of reports have been published dosing the Apc mutant mice with various drugs or drug candidates. We have summarized such experiments in a review (Oshima and Taketo, 2002) . It should be noted that the constitutive isozyme COX-1 also plays a significant role in polyposis ( Figure 3 ) (Chulada et al., 2000) . Introduction of COX-1 mutation into Apc Min mice reduces the number and size of intestinal polyps by B80%, a similar effect by COX-2 mutation (Chulada et al., 2000) . In fact, COX-1 and COX-2 cooperate in polyp formation by supplying PGE 2 that stimulates polyp angiogenesis (Takeda et al., 2003) . Recently, it has been reported that COX-2 inhibitors may cause cardiovascular side effects (Bresalier et al., 2005; Solomon et al., 2005) . Accordingly, COX-2 inhibitors, as well as regular non-steroidal anti-inflammatory drug (NSAIDs) must be prescribed with caution to patients who are at high risk with cardiovascular accidents. Polyp prevention studies with young FAP patients without such risks may be pursued with proper monitoring.
To assess the role of the arachidonic acid (AA)/COX-2/PGE 2 pathway further, we constructed several additional compound mutants of Apc D716 mice with other genes in the pathway. Although COX is the rate-limiting enzyme in the pathway, its substrate AA is not freely available in vivo, but supplied on demand by the activity of phospholipases that cleaves AA from membrane phospholipids. One of the key enzymes in this activity is cytosolic phospholipase A 2 (cPLA 2 ). We introduced a knockout gene for the enzyme into Apc D716 mice, and demonstrated that polyp expansion is reduced significantly . In the downstream of the pathway, on the other hand, the direct metabolite of AA by COX is PGH 2 that is converted further to various prostanoids as PGA 2 , D 2 , F 2a , E 2 , I 2 and thromboxane A 2 (TXA 2 ). Among them, PGE 2 appears to play the major role in polyposis by binding to G-protein-coupled cell surface receptors, EP1, EP2, EP3 and/or EP4. To determine which particular EP receptor is involved in the polyposis phenotype, we introduced knockout mutations for the receptors into Apc D716 mice, respectively, and scored the polyp number and size. The results clearly showed a significant suppression of the polyposis phenotype only in the compound mutant mice with EP2 mutation . Moreover, we found that induction of COX-2 itself, as well as other phenotypes associated with COX-2 induction such as angiogenesis and basement membrane changes, are also mediated by PGE 2 and EP2 receptor. The former phenotype indicates that a positive feedback signal mediated through EP2 and intracellular cyclic AMP regulates COX-2 expression .
It has been reported that PGE 2 indirectly transactivates peroxysome proliferator activator receptor (PPAR)d through phosphoinositide (PI)3K/Akt signaling. Treatment of Apc Min mice with PGE 2 increased intestinal adenoma burden, which was negated in Apc Min mice lacking PPARd, suggesting a crosstalk between the two pathways (Wang et al., 2004) . Other links between the Wnt pathway and COX-2 induction have also been suggested. PGE 2 activates components of the canonical Wnt signaling system. Namely, one of the PGE 2 receptors EP2, activates PI3-kinase and Akt by free G protein bg-subunits, and appears to stimulate direct association of the a-subunit with the RGS domain of axin. This leads to the inactivation and release of GSK3b from its complex with axin, relieving the inhibitory phosphorylation of b-catenin and activating Wnt signaling (Castellone et al., 2005) .
Many other genes have been introduced into Apc polyposis mice, and some have turned out to affect the number of polyps significantly. For example, the DNA helicase gene mutation that is responsible for Bloom syndrome increases the number of intestinal polyps in Apc Min mice (Luo et al., 2000; Heppner Goss et al., 2002) . On the other hand, the mutation for the telomerase RNA gene caused a complex phenotype in Apc Min mice. The polyp numbers increased in several generations, and then decreased thereafter (Rudolph et al., 2001) . Introduction of homozygous mutation in p21, a cyclin inhibitor, into Apc 1638N mice increases tumor multiplicity about twice, and affects goblet cell differentiation (Yang et al., 2001) .
One of matrix metalloproteinases matrilysin (MMP-7) is implicated in cancer invasion and metastasis, and its mutation reduces the polyp number in Apc Min mice, indicating that the enzyme is involved in the formation of adenomatous polyps (Wilson et al., 1997) . With further studies on the regulation of the matrilysin gene, inactivation of the TCF binding site increased its promoter activity whereas overexpression of the TCF factor, LEF-1 downregulated matrilysin promoter activity. These results suggest that b-catenin transactivates the matrilysin promoter by virtue of its ability to abrogate TCFmediated repression (Crawford et al., 1999) . Introduction of homozygous mutation for the inducible nitric oxide synthase (iNOS) gene reduced the polyp number in Apc Min mice by less than half in the small intestine, and to about 10% of the control in the colon, suggesting a possibility in colonic polyp prevention with iNOS-selective inhibitors (Ahn and Oshima, 2001) .
Accumulating evidence indicates that the promoter regions of many cancer-related genes are silenced by methylation of the cytidine residues. Mutations in the DNA methyltransferase gene (Dnmt1), in conjunction with an enzyme inhibitor reduced the polyp number in Apc Min mice from over 100 to less than two, suggesting suppressive effects of DNA hypomethylation on intestinal polyposis (Laird et al., 1995) . On the other hand, introduction of Mbd2 homozygous mutation in Apc Min mice also reduced the polyp numbers to B1/10. As Mbd2 encodes methyl-CpG binding repressor that recruits corepressor complexes to methylated DNA, these results indicate that DNA methylation-mediated gene silencing is integral to the Apc Min polyposis (Sansom et al., 2003) .
The multidrug resistance 1 (Mdr1) gene promoter contains TCF-LEF binding site, and activated by Wnt signaling. In Mdr1-deficient Apc
) were constructed, the polyp number was reduced to almost half of Apc Min mice, although its clinical relevance remains to be investigated (Yamada et al., 2003) .
As described above, all Apc mutant mice develop adenomatous polyps in the small intestine, rather than in the colon. However, our recent studies show that an additional mutation in the Cdx2 gene in Apc D716 mice reverses the polyp localization, shifting most polyps to the colon as in human FAP (Aoki et al., 2003) . Interestingly, the dramatic increase in the colon polyp number is caused by the increased frequency of Apc LOH caused by chromosomal instability (CIN). The latter results from activation of the mTOR pathway and acceleration of the G 1 to S phase transition in the cell cycle (Aoki et al., 2003) . These results present a new mechanism for CIN, and suggest a possibility of treatment and prevention of colon cancer with CIN.
Furthermore, Wnt transcription itself appears to stimulate CIN significantly, although not to the extent caused by Cdx2 mutation. We have recently found significantly high anaphase bridge index (ABI), a marker of CIN, in the intestinal polyp epithelium and ES cells mutated in Apc or b-catenin gene. Importantly, such high ABI were reversed when the cells were introduced with dominant-negative TCF constructs, indicating that transcriptional activation was responsible (Aoki et al., 2006) . Consistent with our observation, it has been shown that Wnt signaling causes CIN via upregulation of conductin (axin2) (Hadjihannas et al., 2006) .
With the use of the Apc mutant mice, more genes have been shown to be modifiers of the Wnt signaling. Although some genes have been defined as the direct targets of Wnt signal activation, more genes are being added to the list. For example, an intestinal crypt transcription factor SOX9 is regulated by the Wnt pathway, and represses the Cdx2 and Muc2 genes (Blache et al., 2004) . While Cdx1 gene has been shown to be a direct target of Wnt signaling during the mouse embryonic development (Lickert et al., 2000) , its gene product CDX1 inhibits human colon cancer cell proliferation by reducing TCF transcriptional activity (Guo et al., 2004) , suggesting a negative feedback regulation.
Lithium is a glycogen synthase kinase-3 inhibitor, and used clinically for the treatment of bipolar disorder. When dosed to the Apc Min mice for 60 days, however, it did not increase the polyp multiplicity, although the overall tumor size increased modestly, which is consistent with the epidemiological evidence that long-term lithium therapy does not increase cancer mortality (Gould et al., 2003) .
Mice lacking Math1, a bHLH transcription factor downstream of the Notch signaling pathway, demonstrate that Math1 is necessary for cell fate determination of the intestinal secretory cells. Hath1, the human homolog of Math1, shows decreased expression in colon cancer cells. Expression of Hath1 in colon cancer cell line HT29 inhibits proliferation, anchorage-independent growth and expression of MUC2. Thus, Math1 and Hath1 may be repressed by the Wnt signaling pathway (Leow et al., 2004 (Leow et al., , 2005 .
When Apc 1638N mice were bred with animals carrying an E-cadherin gene knockout mutation, the intestinal and gastric tumor multiplicity increased nine and five times, respectively, whereas the histopathology of the tumors remained the same (Smits et al., 2000) .
In the Apc Min mouse model of intestinal cancer, genetic abrogation of c-Jun N-terminal phosphorylation or gutspecific conditional c-jun inactivation reduced tumor number and size, and prolonged lifespan. Therefore, the phosphorylation-dependent interaction between c-Jun and TCF3 regulates intestinal tumorigenesis by integrating JNK and APC/b-catenin, two distinct pathways activated by Wnt signaling (Nateri et al., 2005) .
Loss of the mesenchymal transcription factor Foxl1 leads to a marked increase tumor multiplicity in the colon of Apc Min mice (Perrault et al., 2005) . It has been also shown that some of the putative Wnt target genes are not direct targets of the b-catenin/TCF transcription. For example, cyclin D1 has turned out to be induced indirectly as a secondary effect in some cells, but not a direct target of Wnt signaling (Sansom et al., 2005) . Nuclear receptor PPARd is implicated in human colon cancer and mouse intestinal polyposis. Namely, activation of PPARg with two different synthetic agonists increased the number and size of colon tumors in Apc Min mice (Lefebvre et al., 1998) . Interestingly, Wnt/b-catenin signaling targets PPARg in colon cancer cells (Jansson et al., 2005) . However, it has been excluded from the direct targets of the Wnt signal. It does not alter the phenotype of mismatch repair deficiency, either (Reed et al., 2004 (Reed et al., , 2006 . Loss of APC induces histone deacetylase (HDAC)2 expression, depending on the Wnt pathway and c-Myc. Increased HDAC2 expression is found in the majority of human colon cancer explants, as well as in intestinal mucosa and polyps of APC-deficient mice. HDAC2 is required for, and sufficient on its own to prevent, apoptosis of colon cancer cells. Interference with HDAC2 by valproic acid largely diminishes adenoma formation in Apc Min mice. These findings suggest that HDAC2 is a potential target in cancer therapy (Zhu et al., 2004) .
Stabilizing b-catenin mutant mice
As APC forms a complex with other proteins that mediates the Wnt signaling pathway, it is reasonable to ask whether mutations in other components of the complex can also cause polyps in the mouse intestines. In fact, stabilizing mutations in the serine/threonine residues of b-catenin have been identified in a subpopulation of colon cancer that do not carry APC mutations. To test such a possibility experimentally, conditional stabilizing b-catenin mutations have been introduced that are specifically expressed in the intestines. When expression of stabilized b-catenin is induced from calbindin promoter, mice developed only a few polyps in the small intestine (Romagnolo et al., 1999) . When Cre recombinase was driven by cytokeratin 19 (K19) or fatty acid binding protein (FABP) gene promoter to introduce stabilizing mutation in the b-catenin gene, the mice formed 700-3 000 polyps in the small intestine per mouse (Harada et al., 1999) . These results confirm the role of Wnt signaling activation in polyp formation, and indicate that polyps are initiated essentially in the rapidly multiplying cells in the proliferative zone. The floxed b-catenin mutant mice have been used in several other organ systems, providing evidence for the roles of Wnt signaling in prostate tumorigenesis (Gounari et al., 2002) , embryonic and immune system development (Lickert et al., 2000; Gounari et al., 2001 ) and so on.
Mouse models for colon cancer
While all Apc mutant mice develop adenomatous polyps, they do not progress into invasive or metastatic adenocarcinomas at a significant frequency. Owing to the heavy tumor load in the small intestine, most Apc mutant mice die young (4-5 months) due to anemia and cachexia, and some of them by intestinal intussusception. If additional mutations are introduced into these mice, however, the intestinal polyposis phenotypes are modified, and sometimes markedly malignant adenocarcinomas develop.
Mouse models for HNPCC Most HNPCC kindreds carry germline mutations in one of the DNA mismatch repair genes. Although such a defect itself is not the direct cause of colon cancer, mutations in some key genes cannot be repaired. In the human, the genes encoding APC and TGF-b type II receptor are often such targets because of polyA tracks that are prone to mutations. This is not the case in the mouse because the genomic sequences are different from the human. Accordingly, single homozygous mutations in the DNA mismatch repair genes rarely cause adenocarcinomas in the mouse. Interestingly, compound mutant mice of some of these genes can cause adenocarcinomas of the intestines. However, their histopathology is much milder than human colorectal cancer, and no metastasis to the liver or lymph node is observed (Scherer et al., 2005) .
Intestinal cancer with additional mutations in Apc
Min , Apc D716 or Apc 1638N mice We have introduced Smad4 mutation (Figure 2 ) into the Apc D716 polyposis mice, and constructed a model for malignant adenocarcinoma (Takaku et al., 1998) . Although human homologs SMAD4 and APC are on separate chromosomes, the mouse genes are both found on mouse Chr 18, about 30 cM (centimorgan) apart. As polyps are initiated by Apc LOH in Apc D716 intestines, and because this LOH is caused by loss of the entire Chr 18 due to somatic recombination at the ribosomal DNA locus near the centromere, LOH of Apc also results in LOH at Smad4. Taking advantage of this fact, we have constructed mice that carried Apc
D716
and Smad4 mutations on the same chromatid. In the intestinal polyps, both Apc and Smad4 loci are lost, resulting in homozygous mutant cells for both loci. Importantly, the intestinal polyps in these mice progress rapidly into very invasive adenocarcinomas (Takaku et al., 1998) . Interestingly, however, these adenocarcinomas do not metastasize during the short lifespan of these mice. The histopathology is somewhat similar to that of the right side colon cancer in human that is often caused by mutations in the type II receptor for TGF-b. In fact, this model verifies tumor progression by sequential mutations in multiple genes. Moreover, some of these mice also develop adenocarcinomas at the duodenal papilla of Vater, which is one of the complications in human FAP after the colectomy operation.
Homozygous mutation in the Muc2 gene that encodes the most abundant secreted gastrointestinal (GI) mucin causes adenomas and adenocarcinomas in the intestines (Velcich et al., 2002) . Although the incidence and multiplicity are low, the adenocarcinoma is locally invasive without distant metastasis.
Loss of EphB expression strongly correlates with degree of malignancy, and reduction of EphB activity accelerates tumorigenesis in the colon and rectum of Apc Min mice, resulting in the formation of aggressive adenocarcinomas (Batlle et al., 2005) .
A selective Rac GTPase activator Tiam1 is a Wntresponsive gene expressed in the base of intestinal crypts, and upregulated in mouse intestinal tumors and human colon adenomas. When Tiam1 deficiency was introduced into the Apc Min mice, polyp formation and growth were significantly reduced, suggesting a crosstalk between Tiam1-Rac and Wnt-signaling pathways in intestinal carcinogenesis (Malliri et al., 2006) .
Mouse models for gastric cancer
Gastric cancer is still one of the most deadly cancers in many countries (Ushijima and Sasako, 2004) . Although the epidemiologic correlation has been established between Helicobacter pylori infection and gastric carcinogenesis (Correa, 2003) , the molecular mechanism that leads to gastric cancer remains to be elucidated. As only a small fraction of the infected patients develop cancer only after tens of years, it is unlikely that one of H. pyroli gene products directly causes gastric cancer. Rather, it is more reasonable to assume that sustained infection with H. pylori causes a precancerous condition that can lead to carcinogenesis after additional insults. Based on such an 'indirect' mechanism hypothesis, we have focused on the role of prostaglandin (PG) E 2 in earlier stages of gastric carcinogenesis. It is known that Helicobacter infection induces COX-2 and microsomal prostaglandin E synthase (mPGES)-1 in the gastric mucosa (Sung et al., 2000; Oshima et al., 2004) . COX-2 is induced also in gastric cancer tissues (Ristimaki et al., 1997 ). As a model for H. pyroli infected inflammation in the stomach, we constructed transgenic (Tg) mice that simultaneously express COX-2 and mPGES-1 in the gastric mucosa, using cytokeratin 19 gene promoter; 'Tg . K19-C2mE' mice (Oshima et al., 2004) . With the induction of both COX-2 and mPGES-1, PGE 2 production is increased efficiently as in the Helicobacter-infected gastric mucosa. Interestingly, the Tg mice developed metaplasia, and hyperplastic tumors in the glandular stomach, with heavy macrophage infiltrations. Although gastric bacterial counts in the Tg mice were within the normal range, treatment with antibiotics significantly suppressed activation of the macrophages and hyperplastic tumors. Importantly, the antibiotics treatment did not affect the macrophage accumulation. Notably, treatment of the Tg mice with lipopolysaccharides induced proinflammatory cytokines through Toll-like receptor 4 in the gastric epithelial cells. These results indicate that an increased level of PGE 2 enhances macrophage infiltration, and that they are activated through epithelial cells by the gastric flora, resulting in gastric metaplasia and hyperplastic tumors.
To investigate the gastric hyperplastic tumors in the Tg further, we determined the levels of various cytokines and growth factors, and found that TNF-a and interleukin (IL)-1b were significantly increased. We then introduced knockout mutations for TNF-a (Tnf) and IL-1 receptor a chain (Il1r1) genes, respectively. Interestingly, only the compound mutant mice with the Tnf (À/À) Tg . K19-C2mE showed significant suppression of hyperplastic tumors. Importantly, spasmolytic polypeptide (SP)/trefoil factor (TFF)2-expressing metaplasia (SPEM) was also suppressed in the Tnf (À/À)Tg . K19-C2mE mice, indicating that TNF-a-dependent inflammation was responsible for SPEM development (Figure 4, top) . As gastric metaplasia to the SPEM lineage is considered as a preneoplastic lesion of gastric cancer, it is possible that inhibition of TNF-a-dependent inflammation, together with eradication of Helicobacter can be an effective prevention strategy for gastric cancer .
To examine the role of Wnt signaling in gastric carcinogenesis along this context, we have further introduced Wnt1 transgene driven by K19 promoter into the K19-C2mE mice. Although the K19-Wnt1 mice had only small preneoplastic lesions in the stomach, the compound mutant mice Tg . Wnt1/K19-C2mE developed invasive gastric adenocarcinomas by 30 weeks of age (Figure 4 , bottom) (Oshima et al., 2006) . These results clearly demonstrate that Wnt signal activation can contribute to gastric carcinogenesis when accompanied by metaplastic hyperplasia as often associated with Helicobacter infection in the mouse. In this context, it is interesting to note that Apc Min /Fokl1
À/À mice also develop gastric tumors not observed in Apc Min mice, which can be caused by earlier tumor initiation due to accelerated LOH at the Apc locus (Perrault et al., 2005) .
In conclusion, many mouse models have been established that are useful for the investigation of initiation, expansion and progression of GI cancers. They are also valuable tools to evaluate various pharmaceutical and biological agents for prevention and treatment of GI cancers. In most these mouse models, Wnt signal activation plays an essential role for the initiation and progression to malignancy.
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